APO Research

APO RESEARCH · REPORT

Clinical Trials Outsourcing

Selected research

Industry Growth & Trends

Global Clinical Trials Outsourcing Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Clinical Trials Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Clinical Trials Outsourcing market include Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Clinical Trials Outsourcing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Clinical Trials Outsourcing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clinical Trials Outsourcing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Clinical Trials Outsourcing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Clinical Trials Outsourcing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Clinical Trials Outsourcing Market by Company

Charles River Laboratories

IQVIA

ICON PLC

Labcorp Drug Development

Syneos Health

Thermo Fisher Scientific

Wuxi AppTec

Parexel

Advanced Clinical

BioAnalytix

Curia Global

CMED

Cromos Pharma

Criterium

KCR S.A.

Medpace

Medelis

OCT Group

ProTrials Research

PROMETRIKA

Quality Data Service

QPS

Sofpromed

Veristat

Worldwide Clinical Trials

Clinical Trials Outsourcing Segment by Type

Phase I

Phase II

Phase III

Phase IV

Clinical Trials Outsourcing Segment by Application

Cancer

CVDs

Infectious Diseases

Musculoskeletal Diseases

Nervous System Disorders

Others

Clinical Trials Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trials Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trials Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trials Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Clinical Trials Outsourcing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Clinical Trials Outsourcing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Clinical Trials Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Clinical Trials Outsourcing Market Share by Region (2021-2026) Table 4. Global Clinical Trials Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Clinical Trials Outsourcing Market Share by Region (2027-2032) Table 6. Global Clinical Trials Outsourcing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Clinical Trials Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Clinical Trials Outsourcing Market Size Share by Type (2021-2026) Table 9. Global Clinical Trials Outsourcing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Clinical Trials Outsourcing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Clinical Trials Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Clinical Trials Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Clinical Trials Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Clinical Trials Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Clinical Trials Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Clinical Trials Outsourcing Market Size Share by Application (2021-2026) Table 24. Global Clinical Trials Outsourcing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Clinical Trials Outsourcing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Clinical Trials Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Clinical Trials Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Clinical Trials Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Clinical Trials Outsourcing Industry Trends Table 37. Clinical Trials Outsourcing Industry Drivers Table 38. Clinical Trials Outsourcing Industry Opportunities and Challenges Table 39. Clinical Trials Outsourcing Industry Restraints Table 40. Global Clinical Trials Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Clinical Trials Outsourcing Revenue Market Share by Company (2021-2026) Table 42. Global Clinical Trials Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Clinical Trials Outsourcing Key Company Headquarters & Area Served Table 44. Global Clinical Trials Outsourcing Company, Product Type & Application Table 45. Global Clinical Trials Outsourcing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Clinical Trials Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Charles River Laboratories Company Information Table 49. Charles River Laboratories Business Overview Table 50. Charles River Laboratories Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Charles River Laboratories Clinical Trials Outsourcing Product Portfolio Table 52. Charles River Laboratories Recent Development Table 53. IQVIA Company Information Table 54. IQVIA Business Overview Table 55. IQVIA Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. IQVIA Clinical Trials Outsourcing Product Portfolio Table 57. IQVIA Recent Development Table 58. ICON PLC Company Information Table 59. ICON PLC Business Overview Table 60. ICON PLC Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. ICON PLC Clinical Trials Outsourcing Product Portfolio Table 62. ICON PLC Recent Development Table 63. Labcorp Drug Development Company Information Table 64. Labcorp Drug Development Business Overview Table 65. Labcorp Drug Development Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio Table 67. Labcorp Drug Development Recent Development Table 68. Syneos Health Company Information Table 69. Syneos Health Business Overview Table 70. Syneos Health Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Syneos Health Clinical Trials Outsourcing Product Portfolio Table 72. Syneos Health Recent Development Table 73. Thermo Fisher Scientific Company Information Table 74. Thermo Fisher Scientific Business Overview Table 75. Thermo Fisher Scientific Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio Table 77. Thermo Fisher Scientific Recent Development Table 78. Wuxi AppTec Company Information Table 79. Wuxi AppTec Business Overview Table 80. Wuxi AppTec Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Wuxi AppTec Clinical Trials Outsourcing Product Portfolio Table 82. Wuxi AppTec Recent Development Table 83. Parexel Company Information Table 84. Parexel Business Overview Table 85. Parexel Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Parexel Clinical Trials Outsourcing Product Portfolio Table 87. Parexel Recent Development Table 88. Advanced Clinical Company Information Table 89. Advanced Clinical Business Overview Table 90. Advanced Clinical Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Advanced Clinical Clinical Trials Outsourcing Product Portfolio Table 92. Advanced Clinical Recent Development Table 93. BioAnalytix Company Information Table 94. BioAnalytix Business Overview Table 95. BioAnalytix Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. BioAnalytix Clinical Trials Outsourcing Product Portfolio Table 97. BioAnalytix Recent Development Table 98. Curia Global Company Information Table 99. Curia Global Business Overview Table 100. Curia Global Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Curia Global Clinical Trials Outsourcing Product Portfolio Table 102. Curia Global Recent Development Table 103. CMED Company Information Table 104. CMED Business Overview Table 105. CMED Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. CMED Clinical Trials Outsourcing Product Portfolio Table 107. CMED Recent Development Table 108. Cromos Pharma Company Information Table 109. Cromos Pharma Business Overview Table 110. Cromos Pharma Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cromos Pharma Clinical Trials Outsourcing Product Portfolio Table 112. Cromos Pharma Recent Development Table 113. Criterium Company Information Table 114. Criterium Business Overview Table 115. Criterium Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Criterium Clinical Trials Outsourcing Product Portfolio Table 117. Criterium Recent Development Table 118. KCR S.A. Company Information Table 119. KCR S.A. Business Overview Table 120. KCR S.A. Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. KCR S.A. Clinical Trials Outsourcing Product Portfolio Table 122. KCR S.A. Recent Development Table 123. Medpace Company Information Table 124. Medpace Business Overview Table 125. Medpace Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Medpace Clinical Trials Outsourcing Product Portfolio Table 127. Medpace Recent Development Table 128. Medelis Company Information Table 129. Medelis Business Overview Table 130. Medelis Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Medelis Clinical Trials Outsourcing Product Portfolio Table 132. Medelis Recent Development Table 133. OCT Group Company Information Table 134. OCT Group Business Overview Table 135. OCT Group Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. OCT Group Clinical Trials Outsourcing Product Portfolio Table 137. OCT Group Recent Development Table 138. ProTrials Research Company Information Table 139. ProTrials Research Business Overview Table 140. ProTrials Research Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. ProTrials Research Clinical Trials Outsourcing Product Portfolio Table 142. ProTrials Research Recent Development Table 143. PROMETRIKA Company Information Table 144. PROMETRIKA Business Overview Table 145. PROMETRIKA Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. PROMETRIKA Clinical Trials Outsourcing Product Portfolio Table 147. PROMETRIKA Recent Development Table 148. Quality Data Service Company Information Table 149. Quality Data Service Business Overview Table 150. Quality Data Service Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Quality Data Service Clinical Trials Outsourcing Product Portfolio Table 152. Quality Data Service Recent Development Table 153. QPS Company Information Table 154. QPS Business Overview Table 155. QPS Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. QPS Clinical Trials Outsourcing Product Portfolio Table 157. QPS Recent Development Table 158. Sofpromed Company Information Table 159. Sofpromed Business Overview Table 160. Sofpromed Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Sofpromed Clinical Trials Outsourcing Product Portfolio Table 162. Sofpromed Recent Development Table 163. Veristat Company Information Table 164. Veristat Business Overview Table 165. Veristat Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Veristat Clinical Trials Outsourcing Product Portfolio Table 167. Veristat Recent Development Table 168. Worldwide Clinical Trials Company Information Table 169. Worldwide Clinical Trials Business Overview Table 170. Worldwide Clinical Trials Clinical Trials Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio Table 172. Worldwide Clinical Trials Recent Development Table 173. North America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Clinical Trials Outsourcing Market Share by Country (2021-2026) Table 176. North America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Clinical Trials Outsourcing Market Share Forecast by Country (2027-2032) Table 178. Europe Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Clinical Trials Outsourcing Market Share by Country (2021-2026) Table 181. Europe Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Clinical Trials Outsourcing Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Clinical Trials Outsourcing Market Share by Country (2021-2026) Table 186. Asia-Pacific Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Clinical Trials Outsourcing Market Share Forecast by Country (2027-2032) Table 188. Latin America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Clinical Trials Outsourcing Market Share by Country (2021-2026) Table 191. Latin America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Clinical Trials Outsourcing Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Clinical Trials Outsourcing Market Share by Country (2021-2026) Table 196. Middle East & Africa Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Clinical Trials Outsourcing Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Clinical Trials Outsourcing Product Image Figure 3. Global Clinical Trials Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Clinical Trials Outsourcing Market Size (2021-2032) & (US$ Million) Figure 5. Global Clinical Trials Outsourcing Market Share by Region: 2025 VS 2032 Figure 6. Global Clinical Trials Outsourcing Market Share by Region (2021-2032) Figure 7. North America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Clinical Trials Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Phase I Image Figure 13. Global Phase I Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Phase II Image Figure 15. Global Phase II Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Phase III Image Figure 17. Global Phase III Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Phase IV Image Figure 19. Global Phase IV Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Clinical Trials Outsourcing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Clinical Trials Outsourcing Market Share by Type 2025 VS 2032 Figure 22. North America Clinical Trials Outsourcing Market Size Share by Type (2021-2032) Figure 23. Europe Clinical Trials Outsourcing Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Clinical Trials Outsourcing Market Size Share by Type (2021-2032) Figure 25. Latin America Clinical Trials Outsourcing Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Clinical Trials Outsourcing Market Size Share by Type (2021-2032) Figure 27. Cancer Image Figure 28. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. CVDs Image Figure 30. Global CVDs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Infectious Diseases Image Figure 32. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Musculoskeletal Diseases Image Figure 34. Global Musculoskeletal Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nervous System Disorders Image Figure 36. Global Nervous System Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Clinical Trials Outsourcing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Clinical Trials Outsourcing Market Share by Application 2025 VS 2032 Figure 41. North America Clinical Trials Outsourcing Market Size Share by Application (2021-2032) Figure 42. Europe Clinical Trials Outsourcing Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Clinical Trials Outsourcing Market Size Share by Application (2021-2032) Figure 44. Latin America Clinical Trials Outsourcing Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Clinical Trials Outsourcing Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Clinical Trials Outsourcing Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Clinical Trials Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Clinical Trials Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Clinical Trials Outsourcing Market Share by Country (2021-2032) Figure 51. Europe Clinical Trials Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Clinical Trials Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Clinical Trials Outsourcing Market Share by Country (2021-2032) Figure 54. Asia-Pacific Clinical Trials Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Clinical Trials Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Clinical Trials Outsourcing Market Share by Country (2021-2032) Figure 57. Latin America Clinical Trials Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Clinical Trials Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Clinical Trials Outsourcing Market Share by Country (2021-2032) Figure 60. Middle East & Africa Clinical Trials Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Clinical Trials Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Clinical Trials Outsourcing Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Applications
  • Cancer
  • CVDs
  • Infectious Diseases
  • Musculoskeletal Diseases
  • Nervous System Disorders
  • Others
Companies covered
  • Charles River Laboratories
  • IQVIA
  • ICON PLC
  • Labcorp Drug Development
  • Syneos Health
  • Thermo Fisher Scientific
  • Wuxi AppTec
  • Parexel
  • Advanced Clinical
  • BioAnalytix
  • Curia Global
  • CMED
  • Cromos Pharma
  • Criterium
  • KCR S.A.
  • Medpace
  • Medelis
  • OCT Group
  • ProTrials Research
  • PROMETRIKA
  • Quality Data Service
  • QPS
  • Sofpromed
  • Veristat
  • Worldwide Clinical Trials

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Clinical Trials Outsourcing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Clinical Trials Outsourcing Market Size by Region (2021-2032)
  5. 1.4.1 Global Clinical Trials Outsourcing Market Size by Region (2021-2026)
  6. 1.4.2 Global Clinical Trials Outsourcing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Clinical Trials Outsourcing Market Size (2021-2032)
  8. 1.5.1 North America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
2 Clinical Trials Outsourcing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Phase I
  3. 2.1.2 Phase II
  4. 2.1.3 Phase III
  5. 2.1.4 Phase IV
  6. 2.2 Global Clinical Trials Outsourcing Market Size by Type
  7. 2.2.1 Global Clinical Trials Outsourcing Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Clinical Trials Outsourcing Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Clinical Trials Outsourcing Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Clinical Trials Outsourcing Market Size by Regions
  11. 2.3.1 North America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
3 Clinical Trials Outsourcing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 CVDs
  4. 3.1.3 Infectious Diseases
  5. 3.1.4 Musculoskeletal Diseases
  6. 3.1.5 Nervous System Disorders
  7. 3.1.6 Others
  8. 3.2 Global Clinical Trials Outsourcing Market Size by Application
  9. 3.2.1 Global Clinical Trials Outsourcing Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Clinical Trials Outsourcing Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Clinical Trials Outsourcing Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Clinical Trials Outsourcing Market Size by Regions
  13. 3.3.1 North America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Clinical Trials Outsourcing Industry Trends
  2. 4.2 Clinical Trials Outsourcing Industry Drivers
  3. 4.3 Clinical Trials Outsourcing Industry Opportunities and Challenges
  4. 4.4 Clinical Trials Outsourcing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Clinical Trials Outsourcing Revenue (2021-2026)
  2. 5.2 Global Clinical Trials Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Clinical Trials Outsourcing Key Company Headquarters & Area Served
  4. 5.4 Global Clinical Trials Outsourcing Company, Product Type & Application
  5. 5.5 Global Clinical Trials Outsourcing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Clinical Trials Outsourcing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Clinical Trials Outsourcing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Clinical Trials Outsourcing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Charles River Laboratories
  2. 6.1.1 Charles River Laboratories Company Information
  3. 6.1.2 Charles River Laboratories Business Overview
  4. 6.1.3 Charles River Laboratories Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Charles River Laboratories Clinical Trials Outsourcing Product Portfolio
  6. 6.1.5 Charles River Laboratories Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 IQVIA Clinical Trials Outsourcing Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 ICON PLC
  14. 6.3.1 ICON PLC Company Information
  15. 6.3.2 ICON PLC Business Overview
  16. 6.3.3 ICON PLC Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 ICON PLC Clinical Trials Outsourcing Product Portfolio
  18. 6.3.5 ICON PLC Recent Developments
  19. 6.4 Labcorp Drug Development
  20. 6.4.1 Labcorp Drug Development Company Information
  21. 6.4.2 Labcorp Drug Development Business Overview
  22. 6.4.3 Labcorp Drug Development Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio
  24. 6.4.5 Labcorp Drug Development Recent Developments
  25. 6.5 Syneos Health
  26. 6.5.1 Syneos Health Company Information
  27. 6.5.2 Syneos Health Business Overview
  28. 6.5.3 Syneos Health Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Syneos Health Clinical Trials Outsourcing Product Portfolio
  30. 6.5.5 Syneos Health Recent Developments
  31. 6.6 Thermo Fisher Scientific
  32. 6.6.1 Thermo Fisher Scientific Company Information
  33. 6.6.2 Thermo Fisher Scientific Business Overview
  34. 6.6.3 Thermo Fisher Scientific Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio
  36. 6.6.5 Thermo Fisher Scientific Recent Developments
  37. 6.7 Wuxi AppTec
  38. 6.7.1 Wuxi AppTec Company Information
  39. 6.7.2 Wuxi AppTec Business Overview
  40. 6.7.3 Wuxi AppTec Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Wuxi AppTec Clinical Trials Outsourcing Product Portfolio
  42. 6.7.5 Wuxi AppTec Recent Developments
  43. 6.8 Parexel
  44. 6.8.1 Parexel Company Information
  45. 6.8.2 Parexel Business Overview
  46. 6.8.3 Parexel Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Parexel Clinical Trials Outsourcing Product Portfolio
  48. 6.8.5 Parexel Recent Developments
  49. 6.9 Advanced Clinical
  50. 6.9.1 Advanced Clinical Company Information
  51. 6.9.2 Advanced Clinical Business Overview
  52. 6.9.3 Advanced Clinical Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Advanced Clinical Clinical Trials Outsourcing Product Portfolio
  54. 6.9.5 Advanced Clinical Recent Developments
  55. 6.10 BioAnalytix
  56. 6.10.1 BioAnalytix Company Information
  57. 6.10.2 BioAnalytix Business Overview
  58. 6.10.3 BioAnalytix Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 BioAnalytix Clinical Trials Outsourcing Product Portfolio
  60. 6.10.5 BioAnalytix Recent Developments
  61. 6.11 Curia Global
  62. 6.11.1 Curia Global Company Information
  63. 6.11.2 Curia Global Business Overview
  64. 6.11.3 Curia Global Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Curia Global Clinical Trials Outsourcing Product Portfolio
  66. 6.11.5 Curia Global Recent Developments
  67. 6.12 CMED
  68. 6.12.1 CMED Company Information
  69. 6.12.2 CMED Business Overview
  70. 6.12.3 CMED Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 CMED Clinical Trials Outsourcing Product Portfolio
  72. 6.12.5 CMED Recent Developments
  73. 6.13 Cromos Pharma
  74. 6.13.1 Cromos Pharma Company Information
  75. 6.13.2 Cromos Pharma Business Overview
  76. 6.13.3 Cromos Pharma Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cromos Pharma Clinical Trials Outsourcing Product Portfolio
  78. 6.13.5 Cromos Pharma Recent Developments
  79. 6.14 Criterium
  80. 6.14.1 Criterium Company Information
  81. 6.14.2 Criterium Business Overview
  82. 6.14.3 Criterium Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Criterium Clinical Trials Outsourcing Product Portfolio
  84. 6.14.5 Criterium Recent Developments
  85. 6.15 KCR S.A.
  86. 6.15.1 KCR S.A. Company Information
  87. 6.15.2 KCR S.A. Business Overview
  88. 6.15.3 KCR S.A. Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 KCR S.A. Clinical Trials Outsourcing Product Portfolio
  90. 6.15.5 KCR S.A. Recent Developments
  91. 6.16 Medpace
  92. 6.16.1 Medpace Company Information
  93. 6.16.2 Medpace Business Overview
  94. 6.16.3 Medpace Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Medpace Clinical Trials Outsourcing Product Portfolio
  96. 6.16.5 Medpace Recent Developments
  97. 6.17 Medelis
  98. 6.17.1 Medelis Company Information
  99. 6.17.2 Medelis Business Overview
  100. 6.17.3 Medelis Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Medelis Clinical Trials Outsourcing Product Portfolio
  102. 6.17.5 Medelis Recent Developments
  103. 6.18 OCT Group
  104. 6.18.1 OCT Group Company Information
  105. 6.18.2 OCT Group Business Overview
  106. 6.18.3 OCT Group Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 OCT Group Clinical Trials Outsourcing Product Portfolio
  108. 6.18.5 OCT Group Recent Developments
  109. 6.19 ProTrials Research
  110. 6.19.1 ProTrials Research Company Information
  111. 6.19.2 ProTrials Research Business Overview
  112. 6.19.3 ProTrials Research Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 ProTrials Research Clinical Trials Outsourcing Product Portfolio
  114. 6.19.5 ProTrials Research Recent Developments
  115. 6.20 PROMETRIKA
  116. 6.20.1 PROMETRIKA Company Information
  117. 6.20.2 PROMETRIKA Business Overview
  118. 6.20.3 PROMETRIKA Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 PROMETRIKA Clinical Trials Outsourcing Product Portfolio
  120. 6.20.5 PROMETRIKA Recent Developments
  121. 6.21 Quality Data Service
  122. 6.21.1 Quality Data Service Company Information
  123. 6.21.2 Quality Data Service Business Overview
  124. 6.21.3 Quality Data Service Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Quality Data Service Clinical Trials Outsourcing Product Portfolio
  126. 6.21.5 Quality Data Service Recent Developments
  127. 6.22 QPS
  128. 6.22.1 QPS Company Information
  129. 6.22.2 QPS Business Overview
  130. 6.22.3 QPS Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 QPS Clinical Trials Outsourcing Product Portfolio
  132. 6.22.5 QPS Recent Developments
  133. 6.23 Sofpromed
  134. 6.23.1 Sofpromed Company Information
  135. 6.23.2 Sofpromed Business Overview
  136. 6.23.3 Sofpromed Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Sofpromed Clinical Trials Outsourcing Product Portfolio
  138. 6.23.5 Sofpromed Recent Developments
  139. 6.24 Veristat
  140. 6.24.1 Veristat Company Information
  141. 6.24.2 Veristat Business Overview
  142. 6.24.3 Veristat Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Veristat Clinical Trials Outsourcing Product Portfolio
  144. 6.24.5 Veristat Recent Developments
  145. 6.25 Worldwide Clinical Trials
  146. 6.25.1 Worldwide Clinical Trials Company Information
  147. 6.25.2 Worldwide Clinical Trials Business Overview
  148. 6.25.3 Worldwide Clinical Trials Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio
  150. 6.25.5 Worldwide Clinical Trials Recent Developments
7 North America
  1. 7.1 North America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Clinical Trials Outsourcing Market Size by Country (2021-2026)
  3. 7.3 North America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Clinical Trials Outsourcing Market Size by Country (2021-2026)
  3. 8.3 Europe Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Clinical Trials Outsourcing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Clinical Trials Outsourcing Market Size by Country (2021-2026)
  3. 10.3 South America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research